Clinicopathologic features and treatment outcome of primary breast diffuse large B-cell lymphoma

Leukemia Research

Volumn 32, Issue 12, 2008, Pages 1837-1841

  Niitsu, Nozomi ^a,b   Okamoto, Masataka ^b   Nakamine, Hirokazu ^b   Hirano, Masami ^b  

^a International Medical Center   (Japan)

^b Adult Lymphoma Treatment Study Group ALTSG   (Japan)

Author keywords

BCL 6; Breast lymphoma; Diffuse large B cell lymphoma; Germinal center B cell; MUM 1

Indexed keywords

ANTHRACYCLINE; ANTIINFECTIVE AGENT; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INTERFERON REGULATORY FACTOR 4; PROTEIN BCL 2; PROTEIN BCL 6;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BREAST TUMOR; CANCER RADIOTHERAPY; CANCER STAGING; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD5; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEPRILYSIN; SURVIVAL ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 51649089821     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.04.005     Document Type: Article

References (18)

1. Ribrag V., Bibeau F., El Weshi A., Frayfer J., Fadel C., Cebotaru C., et al. Primary breast lymphoma: a report of 20 cases. Br J Haematol 115 (2001) 253-256
2. López-Guillermo A., Colomo L., Jiménez M., Bosch F., Villamor N., Arenillas L., et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 23 April (20) (2005) 2797-2804
3. Ryan G.F., Roos D.R., and Seymour J.F. Primary non-Hodgkin's lymphoma of the breast: retrospective analysis of prognosis and patterns of failure in two Australian centers. Clin Lymphoma Myeloma 6 (2006) 337-341
4. Wong W.M., Schild S.E., Halyard M.Y., and Schomberg P.J. Primary non-Hodgkin's of the breast: the Mayo clinic experience. J Surg Oncol 80 (2002) 19-25
5. Liu M.T., Hsieh C.Y., Wang A.Y., Pi C.P., Chang T.H., Huang C.C., et al. Primary breast lymphoma: a pooled analysis of prognostic factors and survival in 93 cases. Ann Saudi Med 25 (2005) 288-293
6. Giardini R., Piccolo C., and Rilke F. Primary non-Hodgkin's lymphomas of the female breast. Cancer 69 (1992) 725-735
7. Ganjoo K., Advani R., Mariappan M.R., McMillan A., and Horning S. Non-Hodgkin lymphoma of the breast. Cancer 110 (2007) 25-30
8. Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: Int Agency Res Cancer (2001) P171-P174
9. Hashimoto K., Miura I., Chyubachi A., Saito M., and Miura A.B. Correlations of chromosome abnormalities with histologic and immunologic characteristics in 49 patients from Akita, Japan with non-Hodgkin lymphoma. Cancer Genet Cytogenet 81 (1995) 56-65
10. Mitelman F. An International System for Human Cytogenetic Nomenclature. 1995 ISCN, S Karger, Basel.
11. Shipp M.A. International non-Hodgkin's lymphoma prognostic factors project: a predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329 (1993) 987-994
12. Niitsu N., Okamoto M., Aoki S., Okumura H., Tadashi Y., Miura I., et al. Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma. Ann Haematol 85 (2006) 374-380
13. Hans C.P., Weisenburger D.D., Greiner T.C., Gascoyne R.D., Delabie J., Ott G., et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 (2004) 275-282
14. Barişta I., Baltali E., Tekuzman G., Kars A., Ruacan S., Ozişik Y., et al. Primary breast lymphomas-a retrospective analysis of 12 cases. Acta Oncol 39 (2000) 135-139
15. Avilés A., Castañeda C., Neri N., Cleto S., and Nambo M.J. Rituximab and dose dense chemotherapy in primary breast lymphoma. Haematologica 92 (2007) 1147-1148
16. Ryan G., et al., International Extranodal Lymphoma Study Group. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol 19 (2008) 233-241
17. Yoshida S., Nakamura N., Sasaki Y., Yoshida S., Yasuda M., Samara H., et al. Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype. Modern Pathol 18 (2005) 398-405
18. Fruchart C., Denoux Y., Chasle J., Peny A.M., Boute V., Ollivier J.M., et al. High-grade primary breast lymphoma: is it a different clinical entity?. Breast Cancer Res Treat 93 (2005) 191-198